Column - January 25, 2023
A high-level take on recent trends in healthcare
Healthcare stock indices enjoyed a decade-long growth-phase until and including 2017. IPOs within the sector, at arguably far too steep valuations, continued riding on this growth phase, peaking somewhat later in 2020-2021. This phase culminated with a growing number of disappointments between 2020-1H 2022, driven first by gene therapies, then oncology and in neurodegenerative diseases. […]
Column - June 20, 2022
Advice to smaller listed Swedish Life Science companies
Most listed Swedish biotech companies have cash and financing that is sufficient to last until 2023 or longer. The few who do not have this should probably hurry while there is time. During 2023-2025, many companies will return for new funds and competition will be fierce. In addition, there are also many listed diagnostics and […]
Column - November 21, 2019
Column: The Trick is Staying Inspired
As the new Program Director of NLSDays, I am fortunate to be given a platform to address important issues within our life science community. In this medium, I would first like to introduce myself and a bit about how I arrived. I dreamt of global entrepreneurship, believing business would be my conduit to positively impacting […]
Column - October 15, 2018
Health tech – the new Nordic export?
Artificial Intelligence, Virtual Reality, Machine Learning, 3D printers, Big Data, Apps, Robotics, Cloud Computing, Digital pills, Wearables, eHealth, mHealth, Patient entrepreneurs … The list of buzz words within digital health, or health tech, is long and expectations are high that this rapidly emerging field will revolutionize healthcare, where technology itself can also be a treatment. […]
